Physician profile
Michael J Dunn
NPI 1144218157
$3,026.19
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $127 · 2020: $1,282 · 2021: $110 · 2022: $1,344 · 2023: $125 · 2024: $38.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $163.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,233.86 | 2020 | |
| Catalyst Orthoscience | $680.72 | 2022 | |
| Zimmer Biomet Holdings, INC. | $663.04 | 2022 | |
| Stryker Corporation | $144.31 | 2021-2023 | Aequalis Perform+, Aequalis Perform |
| Si-Bone, INC. | $54.05 | 2019-2020 | |
| Team 1, LLC | $47.14 | 2023-2024 | |
| Pacira Therapeutics, INC. | $44.35 | 2019 | |
| Depuy Synthes Sales INC. | $40.59 | 2019-2021 | |
| Fidia Pharma USA INC. | $38.65 | 2020-2024 | Hymovis, Hyalgan, Triluron |
| Sonex Health, INC. | $32.33 | 2023 | Sx-One Microknife |
| Boston Scientific Corporation | $16.65 | 2021 | |
| Medtronic Vascular, INC. | $15.72 | 2019 | |
| Providence Medical Technology, INC. | $14.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Dunn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.